{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:27:11Z","timestamp":1793406431515,"version":"4.5.0"},"reference-count":33,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,11,12]]},"DOI":"10.1167\/iovs.66.14.19","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:30:48Z","timestamp":1762954248000},"page":"19","source":"Crossref","is-referenced-by-count":3,"title":["Cefiderocol and Moxifloxacin Have Additive and Synergistic Activity Against\n                    <i>Pseudomonas aeruginosa<\/i>\n                    Including an Isolate of the 2023 Keratitis Outbreak"],"prefix":"10.1167","volume":"66","author":[{"given":"Eric G.","family":"Romanowski","sequence":"first","affiliation":[{"name":"Charles T. Campbell Laboratory, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brennan M.","family":"Schilling","sequence":"additional","affiliation":[{"name":"Department of Surgery, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Young","sequence":"additional","affiliation":[{"name":"Charles T. Campbell Laboratory, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya M.","family":"Mumper","sequence":"additional","affiliation":[{"name":"Charles T. Campbell Laboratory, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Zegans","sequence":"additional","affiliation":[{"name":"Department of Surgery, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M. Q.","family":"Shanks","sequence":"additional","affiliation":[{"name":"Charles T. Campbell Laboratory, Department of Ophthalmology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ceo.14113","article-title":"Infectious keratitis: a review","volume":"50","author":"Cabrera-Aguas","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.ophtha.2017.05.012","article-title":"Update on the management of infectious keratitis","volume":"124","author":"Austin","year":"2017","journal-title":"Ophthalmology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1099\/jmm.0.001110","article-title":"Pseudomonas aeruginosa and microbial keratitis","volume":"69","author":"Hilliam","year":"2020","journal-title":"J Med Microbiol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"108647","DOI":"10.1016\/j.exer.2021.108647","article-title":"Foundational concepts in the biology of bacterial keratitis","volume":"209","author":"Ung","year":"2021","journal-title":"Exp Eye Res"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jtos.2025.06.008","article-title":"Moxifloxacin-resistant and moxifloxacin-susceptible Staphylococcus aureus keratitis: outcomes from a 10-year retrospective study","volume":"38","author":"Diacou","year":"2025","journal-title":"Ocul Surf"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/bjophthalmol-2021-320203","article-title":"Multidrug-resistant keratitis: challenging yet manageable","volume":"107","author":"Sahoo","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/13543784.2018.1426745","article-title":"Cefiderocol: a novel siderophore cephalosporin","volume":"27","author":"Choi","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.3390\/microorganisms10061247","article-title":"Resistance is not futile: the role of quorum sensing plasticity in Pseudomonas aeruginosa infections and its link to intrinsic mechanisms of antibiotic resistance","volume":"10","author":"Simanek","year":"2022","journal-title":"Microorganisms"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1073\/pnas.0307694100","article-title":"Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication","volume":"101","author":"Deziel","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-2958.2007.05678.x","article-title":"Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients","volume":"64","author":"D'Argenio","year":"2007","journal-title":"Mol Microbiol"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"e00140","DOI":"10.1128\/mSphere.00140-16","article-title":"Environmentally endemic Pseudomonas aeruginosa strains with mutations in lasR are associated with increased disease severity in corneal ulcers","volume":"1","author":"Hammond","year":"2016","journal-title":"mSphere"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2018.10.018","article-title":"Bacterial Keratitis Preferred Practice Pattern(R)","volume":"126","author":"Lin","year":"2019","journal-title":"Ophthalmology"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"102311","DOI":"10.1016\/j.clae.2024.102311","article-title":"Combination effect of levofloxacin and cefmenoxime against ocular isolates of Pseudomonas aeruginosa","volume":"47","author":"Itoi","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1097\/ICO.0000000000003528","article-title":"Efficacy of a novel antibiotic drug combination toward multidrug-resistant ocular pathogens","volume":"43","author":"Gowtham","year":"2024","journal-title":"Cornea"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1097\/ICO.0000000000003304","article-title":"Antimicrobial drug\u2013drug interactions in the treatment of infectious keratitis","volume":"42","author":"Dunster","year":"2023","journal-title":"Cornea"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"107560","DOI":"10.1016\/j.micpath.2025.107560","article-title":"An assessment of cefiderocol's synergistic effects with eravacycline, colistin, meropenem, levofloxacin, ceftazidime\/avibactam, and tobramycin against carbapenem-resistant and -susceptible Pseudomonasa aeruginosa","volume":"204","author":"Mataraci-Kara","year":"2025","journal-title":"Microb Pathog"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"e0118823","DOI":"10.1128\/mra.01188-23","article-title":"Genome sequence generated by hybrid Nanopore-Illumina assembly of an extensively drug-resistant Pseudomonas aeruginosa strain from a keratitis outbreak","volume":"13","author":"Calvario","year":"2024","journal-title":"Microbiol Resour Announc"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3390\/antibiotics13100979","article-title":"The efficacy of topical cefiderocol treatment of experimental extensively drug-resistant Pseudomonas aeruginosa keratitis is dependent upon the state of the corneal epithelium","volume":"13","author":"Romanowski","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"100452","DOI":"10.1016\/j.xops.2023.100452","article-title":"Cefiderocol is an effective topical monotherapy for experimental extensively drug-resistant Pseudomonas aeruginosa keratitis","volume":"4","author":"Romanowski","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"e00951","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol antimicrobial susceptibility testing considerations: the Achilles\u2019 heel of the Trojan Horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/AAC.40.8.1914","article-title":"Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1128\/AAC.35.12.2649","article-title":"Development of resistance to ciprofloxacin in nutrient-rich and nutrient-limited growth conditions in vitro by Pseudomonas aeruginosa isolates from patients with cystic fibrosis","volume":"35","author":"Ferguson","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1286842","DOI":"10.3389\/fcimb.2023.1286842","article-title":"A rise in the frequency of lasR mutant Pseudomonas aeruginosa among keratitis isolates between 1993 and 2021","volume":"13","author":"Shanks","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/00055735-200408000-00007","article-title":"Fourth-generation fluoroquinolones: new topical agents in the war on ocular bacterial infections","volume":"15","author":"Mah","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s12325-008-0107-x","article-title":"Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy","volume":"25","author":"Scoper","year":"2008","journal-title":"Adv Ther"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/ICO.0000000000000352","article-title":"Seasonal, geographic, and antimicrobial resistance patterns in microbial keratitis: 4-year experience in eastern Pennsylvania","volume":"34","author":"Ni","year":"2015","journal-title":"Cornea"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/ICO.0000000000001417","article-title":"Bacterial keratitis: isolated organisms and antibiotic resistance patterns in San Francisco","volume":"37","author":"Peng","year":"2018","journal-title":"Cornea"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/bjophthalmol-2017-311751","article-title":"Comparative activity of antimicrobials against Pseudomonas aeruginosa, Achromobacter xylosoxidans and Stenotrophomonas maltophilia keratitis isolates","volume":"102","author":"Spierer","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/ICO.0000000000003198","article-title":"Microbial keratitis isolates at a midwestern tertiary eye care center","volume":"42","author":"Kang","year":"2023","journal-title":"Cornea"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/09286586.2013.790978","article-title":"Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India","volume":"20","author":"Oldenburg","year":"2013","journal-title":"Ophthalmic Epidemiol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1574-6968.1998.tb13910.x","article-title":"Quorum-sensing and siderophore biosynthesis in Pseudomonas aeruginosa: lasR\/lasI mutants exhibit reduced pyoverdine biosynthesis","volume":"166","author":"Stintzi","year":"1998","journal-title":"FEMS Microbiol Lett"},{"key":"bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/OPTH.S5778","article-title":"Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics","volume":"3","author":"Bertino","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"bib21","article-title":"Outbreak of extensively drug-resistant Pseudomonas aeruginosa associated with artificial tears","author":"CDC"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:59Z","timestamp":1791927119000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.14.19","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}